Live Breaking News & Updates on Amicus Therapeutics Company Profile

Stay updated with breaking news from Amicus therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hillsdale Investment Management Inc. Acquires 23,640 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)

Hillsdale Investment Management Inc. lifted its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 8.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 294,300 shares of the biopharmaceutical company’s stock after purchasing an additional 23,640 shares during the period. Hillsdale […] ....

United States , Margaretg Mcglynn , E Fund Management Co , Profund Advisors , Fund Management Co , Amicus Therapeutics Inc , Jpmorgan Chase Co , Hillsdale Investment Management Inc , Amicus Therapeutics Company Profile , Associates Corp , Morgan Stanley , Needham Company , Amicus Therapeutics , Hillsdale Investment Management , Free Report , Investment Management , State Retirement System , Fund Management , Director Margaret , Get Free Report , Visit Holdingschannel , Amicus Therapeutics Daily ,